Back to today’s briefing

Story perspectives

GLP-1 Drugs Slash Dementia Risk by 45%: Study

4/16/2025

23 5

Summary

Story summary

Recent studies reveal that GLP-1 receptor agonists, such as Ozempic, could significantly reduce the risk of dementia by 45% among users, based on research with over 160,000 participants. However, these medications do not appear to affect vascular dementia or Alzheimer's, highlighting the need for further investigation into newer GLP-1RAs.

1 of 1

Story summary

Recent studies reveal that GLP-1 receptor agonists, such as Ozempic, could significantly reduce the risk of dementia by 45% among users, based on research with over 160,000 participants. However, these medications do not appear to affect vascular dementia or Alzheimer's, highlighting the need for further investigation into newer GLP-1RAs.